ID   SKN1_CAEEL              Reviewed;         623 AA.
AC   P34707; Q8MPW2; Q8MPW3;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   18-JUN-2025, entry version 205.
DE   RecName: Full=Protein skinhead-1;
GN   Name=skn-1; ORFNames=T19E7.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 49-623 (ISOFORM A), FUNCTION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Bristol N2;
RX   PubMed=1547503; DOI=10.1016/0092-8674(92)90078-q;
RA   Bowerman B., Eaton B.A., Priess J.R.;
RT   "skn-1, a maternally expressed gene required to specify the fate of ventral
RT   blastomeres in the early C. elegans embryo.";
RL   Cell 68:1061-1075(1992).
RN   [3]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND DNA-BINDING.
RX   PubMed=7939715; DOI=10.1126/science.7939715;
RA   Blackwell T.K., Bowerman B., Priess J.R., Weintraub H.;
RT   "Formation of a monomeric DNA binding domain by Skn-1 bZIP and homeodomain
RT   elements.";
RL   Science 266:621-628(1994).
RN   [4]
RP   FUNCTION.
RX   PubMed=11463373; DOI=10.1016/s1097-2765(01)00195-2;
RA   Maduro M.F., Meneghini M.D., Bowerman B., Broitman-Maduro G., Rothman J.H.;
RT   "Restriction of mesendoderm to a single blastomere by the combined action
RT   of SKN-1 and a GSK-3beta homolog is mediated by MED-1 and -2 in C.
RT   elegans.";
RL   Mol. Cell 7:475-485(2001).
RN   [5]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-164 AND SER-430, AND
RP   MUTAGENESIS OF SER-164 AND SER-430.
RX   PubMed=16166371; DOI=10.1101/gad.1324805;
RA   Inoue H., Hisamoto N., An J.H., Oliveira R.P., Nishida E., Blackwell T.K.,
RA   Matsumoto K.;
RT   "The C. elegans p38 MAPK pathway regulates nuclear localization of the
RT   transcription factor SKN-1 in oxidative stress response.";
RL   Genes Dev. 19:2278-2283(2005).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20624915; DOI=10.1074/jbc.m110.146274;
RA   Okuyama T., Inoue H., Ookuma S., Satoh T., Kano K., Honjoh S., Hisamoto N.,
RA   Matsumoto K., Nishida E.;
RT   "The ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like
RT   signaling in Caenorhabditis elegans.";
RL   J. Biol. Chem. 285:30274-30281(2010).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22216003; DOI=10.1371/journal.ppat.1002453;
RA   Hoeven R.V., McCallum K.C., Cruz M.R., Garsin D.A.;
RT   "Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1
RT   activity via p38 MAPK signaling during infection in C. elegans.";
RL   PLoS Pathog. 7:E1002453-E1002453(2011).
RN   [8] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 240-ARG--ILE-623.
RX   PubMed=22568582; DOI=10.1111/j.1474-9726.2012.00831.x;
RA   Rizki G., Picard C.L., Pereyra C., Lee S.S.;
RT   "Host cell factor 1 inhibits SKN-1 to modulate oxidative stress responses
RT   in Caenorhabditis elegans.";
RL   Aging Cell 11:717-721(2012).
RN   [9]
RP   FUNCTION, INTERACTION WITH PGAM-5 AND MXL-3, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF GLU-237 AND SER-245.
RX   PubMed=23040073; DOI=10.1016/j.cmet.2012.09.007;
RA   Paek J., Lo J.Y., Narasimhan S.D., Nguyen T.N., Glover-Cutter K.,
RA   Robida-Stubbs S., Suzuki T., Yamamoto M., Blackwell T.K., Curran S.P.;
RT   "Mitochondrial SKN-1/Nrf mediates a conserved starvation response.";
RL   Cell Metab. 16:526-537(2012).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23106139; DOI=10.1111/jnc.12072;
RA   VanDuyn N., Settivari R., LeVora J., Zhou S., Unrine J., Nass R.;
RT   "The metal transporter SMF-3/DMT-1 mediates aluminum-induced dopamine
RT   neuron degeneration.";
RL   J. Neurochem. 124:147-157(2013).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23721876; DOI=10.1016/j.neuro.2013.05.014;
RA   Settivari R., VanDuyn N., LeVora J., Nass R.;
RT   "The Nrf2/SKN-1-dependent glutathione S-transferase pi homologue GST-1
RT   inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of
RT   manganism.";
RL   NeuroToxicology 38:51-60(2013).
RN   [12]
RP   FUNCTION.
RX   PubMed=24385935; DOI=10.1371/journal.pgen.1004063;
RA   Ghose P., Park E.C., Tabakin A., Salazar-Vasquez N., Rongo C.;
RT   "Anoxia-reoxygenation regulates mitochondrial dynamics through the hypoxia
RT   response pathway, SKN-1/Nrf, and stomatin-like protein STL-1/SLP-2.";
RL   PLoS Genet. 9:E1004063-E1004063(2013).
RN   [13]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25688864; DOI=10.1371/journal.pone.0117444;
RA   Mendes T.K., Novakovic S., Raymant G., Bertram S.E., Esmaillie R.,
RA   Nadarajan S., Breugelmans B., Hofmann A., Gasser R.B., Colaiacovo M.P.,
RA   Boag P.R.;
RT   "Investigating the role of RIO protein kinases in Caenorhabditis elegans.";
RL   PLoS ONE 10:E0117444-E0117444(2015).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=27528192; DOI=10.7554/elife.17721;
RA   Lehrbach N.J., Ruvkun G.;
RT   "Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic
RT   protease DDI-1.";
RL   Elife 5:0-0(2016).
RN   [15]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, PHOSPHORYLATION AT SER-164 AND
RP   SER-430, AND MUTAGENESIS OF SER-164 AND SER-430.
RX   PubMed=26920757; DOI=10.1534/genetics.115.185272;
RA   McCallum K.C., Liu B., Fierro-Gonzalez J.C., Swoboda P., Arur S.,
RA   Miranda-Vizuete A., Garsin D.A.;
RT   "TRX-1 Regulates SKN-1 Nuclear Localization Cell Non-autonomously in
RT   Caenorhabditis elegans.";
RL   Genetics 203:387-402(2016).
RN   [16]
RP   FUNCTION, INTERACTION WITH ELT-3, AND SUBCELLULAR LOCATION (ISOFORMS B AND
RP   C).
RX   PubMed=28600327; DOI=10.1534/genetics.116.198788;
RA   Hu Q., D'Amora D.R., MacNeil L.T., Walhout A.J.M., Kubiseski T.J.;
RT   "The Oxidative Stress Response in Caenorhabditis elegans Requires the GATA
RT   Transcription Factor ELT-3 and SKN-1/Nrf2.";
RL   Genetics 206:1909-1922(2017).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION (ISOFORMS B AND C), AND MUTAGENESIS OF
RP   553-GLN--ILE-623.
RX   PubMed=34407394; DOI=10.1016/j.celrep.2021.109529;
RA   Wu C., Karakuzu O., Garsin D.A.;
RT   "Tribbles pseudokinase NIPI-3 regulates intestinal immunity in
RT   Caenorhabditis elegans by controlling SKN-1/Nrf activity.";
RL   Cell Rep. 36:109529-109529(2021).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 540-623.
RX   PubMed=9628487; DOI=10.1038/nsb0698-484;
RA   Rupert P.B., Daughdrill G.W., Bowerman B., Matthews B.W.;
RT   "A new DNA-binding motif in the Skn-1 binding domain-DNA complex.";
RL   Nat. Struct. Biol. 5:484-491(1998).
CC   -!- FUNCTION: Transcription factor (PubMed:1547503, PubMed:28600327).
CC       Required to specify the fate of ventral blastomeres in the early
CC       embryo, and postembryonically for the development of the intestine
CC       (PubMed:1547503). Directly regulates expression of zygotically
CC       expressed med-1 and med-2 to direct mesendoderm development
CC       (PubMed:11463373, PubMed:1547503). In response to oxidative stress and
CC       anoxia, required to up-regulate expression of stl-1 mRNA
CC       (PubMed:24385935). Involved in regulating innate immunity, acting
CC       downstream of the pmk-1 p38/MAPK pathway and probably also downstream
CC       of nipi-3 (PubMed:34407394). Required for the up-regulation of phase II
CC       detoxification genes, including gcs-1 and several glutathione-S-
CC       transferase mRNAs in response to oxidative stress generated during
CC       pathogenic bacterial infection (PubMed:22216003). Modulates oxidative
CC       stress responses in concert with transcription factors such as hcf-1
CC       and elt-3 (PubMed:22568582, PubMed:28600327). Regulates the
CC       transcription of genes associated with metabolism in response to
CC       changes in nutrient availability (PubMed:23040073). In neurons,
CC       involved in mitochondrial fusion and behavioral recovery during
CC       reoxygenation (PubMed:24385935). Required for riok-1 mRNA expression in
CC       the intestine (PubMed:25688864). Downstream of the let-60/Ras, mek-2
CC       and pmk-1 pathway, positively regulates lifespan probably by preventing
CC       transcription of insulin-like peptides such as ins-39
CC       (PubMed:20624915). Prevents degeneration of dopaminergic CEP neurons in
CC       response to high Al(3+) or Mn(2+) levels, probably by promoting the
CC       expression of glutathione-S-transferase gst-1 (PubMed:23106139,
CC       PubMed:23721876). {ECO:0000269|PubMed:11463373,
CC       ECO:0000269|PubMed:1547503, ECO:0000269|PubMed:20624915,
CC       ECO:0000269|PubMed:22216003, ECO:0000269|PubMed:22568582,
CC       ECO:0000269|PubMed:23040073, ECO:0000269|PubMed:23106139,
CC       ECO:0000269|PubMed:23721876, ECO:0000269|PubMed:24385935,
CC       ECO:0000269|PubMed:25688864}.
CC   -!- FUNCTION: [Isoform a]: Directed by the ER-associated degradation
CC       pathway (ERAD), mediates proteasomal homeostasis by regulating the
CC       expression of proteasomal subunits such as rpt-3 to confer resistance
CC       to proteasomal dysfunction. {ECO:0000269|PubMed:27528192}.
CC   -!- SUBUNIT: Monomer (PubMed:7939715). Interacts with GATA factor elt-3;
CC       interaction may enhance transcriptional activation of target genes
CC       (PubMed:28600327). {ECO:0000269|PubMed:28600327,
CC       ECO:0000269|PubMed:7939715}.
CC   -!- SUBUNIT: [Isoform a]: Interacts with pgma-5 (PubMed:23040073).
CC       Interacts with transcription factor mxl-3 (via N-terminus)
CC       (PubMed:23040073). {ECO:0000269|PubMed:23040073}.
CC   -!- SUBUNIT: [Isoform c]: Interacts with pgma-5 (PubMed:23040073).
CC       Interacts with transcription factor mxl-3 (via N-terminus)
CC       (PubMed:23040073). {ECO:0000269|PubMed:23040073}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16166371,
CC       ECO:0000269|PubMed:22216003, ECO:0000269|PubMed:26920757,
CC       ECO:0000269|PubMed:7939715}. Cytoplasm {ECO:0000269|PubMed:16166371,
CC       ECO:0000269|PubMed:22216003, ECO:0000269|PubMed:26920757}. Note=In
CC       absence of stress, localizes in the cytoplasm of intestinal cells
CC       (PubMed:16166371, PubMed:22216003, PubMed:26920757). Upon paraquat or
CC       arsenite treatments or upon bacterial infection, localizes in the
CC       nucleus (PubMed:16166371, PubMed:22216003, PubMed:26920757). Nuclear
CC       localization is regulated by pmk-1-mediated phosphorylation
CC       (PubMed:16166371, PubMed:26920757). Nuclear localization is regulated
CC       by transcriptional coregulator hcf-1. {ECO:0000269|PubMed:16166371,
CC       ECO:0000269|PubMed:22216003, ECO:0000269|PubMed:22568582,
CC       ECO:0000269|PubMed:26920757}.
CC   -!- SUBCELLULAR LOCATION: [Isoform a]: Nucleus
CC       {ECO:0000269|PubMed:27528192}. Mitochondrion
CC       {ECO:0000269|PubMed:23040073}. Note=Localizes to the nucleus in
CC       response to proteasomal dysfunction. {ECO:0000269|PubMed:27528192}.
CC   -!- SUBCELLULAR LOCATION: [Isoform b]: Nucleus
CC       {ECO:0000269|PubMed:28600327, ECO:0000269|PubMed:34407394}.
CC       Note=Localizes to the nucleus in response to pathogenic bacteria such
CC       as P.aeruginosa or E.faecalis, in a nipi-3-dependent manner
CC       (PubMed:34407394). Localizes to the nucleus in a brap-2-dependent
CC       manner (PubMed:28600327). {ECO:0000269|PubMed:28600327,
CC       ECO:0000269|PubMed:34407394}.
CC   -!- SUBCELLULAR LOCATION: [Isoform c]: Nucleus
CC       {ECO:0000269|PubMed:28600327, ECO:0000269|PubMed:34407394}.
CC       Note=Localizes to the nucleus in response to pathogenic bacteria such
CC       as P.aeruginosa or E.faecalis, in a nipi-3-dependent manner
CC       (PubMed:34407394). Localizes to the nucleus in a brap-2-dependent
CC       manner (PubMed:28600327). {ECO:0000269|PubMed:28600327,
CC       ECO:0000269|PubMed:34407394}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a;
CC         IsoId=P34707-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P34707-2; Sequence=VSP_011488, VSP_011489;
CC       Name=c;
CC         IsoId=P34707-3; Sequence=VSP_011487;
CC   -!- TISSUE SPECIFICITY: Postembryonic intestinal cells.
CC       {ECO:0000269|PubMed:1547503, ECO:0000269|PubMed:26920757}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       {ECO:0000269|PubMed:1547503}.
CC   -!- DOMAIN: Alternative DNA-binding strategy due to lack of a leucine
CC       zipper dimerization segment: DNA binding domain binds to its cognate
CC       half-site, an N-terminal arm recognizes adjacent 5' AT-rich sequences
CC       in the minor groove and the intervening residues stabilize interactions
CC       of these two subdomains with DNA. {ECO:0000269|PubMed:9628487}.
CC   -!- PTM: [Isoform a]: Cleaved by the aspartic protease ddi-1.
CC       {ECO:0000269|PubMed:27528192}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown of all isoforms results
CC       in a severe reduction in transcription of gst-4, gst-5, gst-7 and gcs-1
CC       mRNAs during infection by P.aeruginosa or P.faecalis (PubMed:22216003).
CC       Susceptibility to P.aeruginosa and P.faecalis is characterized by a
CC       decrease in survival rate (PubMed:22216003).
CC       {ECO:0000269|PubMed:22216003}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform a]: Viable, but there is failed
CC       activation of the expression of the proteasomal subunit rpt-3 in all
CC       tissues (PubMed:27528192). Treatment with the proteasome inhibitor
CC       bortezomib or knockout with rpn-10 RNAi results in larval lethality
CC       (PubMed:27528192). Double knockout with pbs-5 results in failed
CC       expression the proteasomal subunit rpt-3 (PubMed:27528192). Also causes
CC       a loss of transcription of riok-1 mRNA in intestine (PubMed:25688864).
CC       Reduces life span (PubMed:20624915). Moderate increase in transcription
CC       of ins-39 mRNA (PubMed:20624915). Moderate increase in CEP neuron death
CC       in response to high Al(3+) levels (PubMed:23106139). RNAi-mediated
CC       knockdown causes an increase in Mn(2+)-mediated dopaminergic CEP neuron
CC       degeneration and a reduction in expression levels of glutathione S-
CC       transferase gst-1 (PubMed:23721876). {ECO:0000269|PubMed:20624915,
CC       ECO:0000269|PubMed:22216003, ECO:0000269|PubMed:23106139,
CC       ECO:0000269|PubMed:23721876, ECO:0000269|PubMed:25688864,
CC       ECO:0000269|PubMed:27528192}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform c]: RNAi-mediated knockdown decreases
CC       gst-4 mRNA expression in a brap-2 mutant background.
CC       {ECO:0000269|PubMed:28600327}.
CC   -!- SIMILARITY: Belongs to the bZIP family. Skn1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284604; CCD62212.1; -; Genomic_DNA.
DR   EMBL; BX284604; CCD62213.1; -; Genomic_DNA.
DR   EMBL; BX284604; CCD62214.1; -; Genomic_DNA.
DR   EMBL; M84359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A42143; A42143.
DR   PIR; F88694; F88694.
DR   RefSeq; NP_001367379.1; NM_001380237.1. [P34707-3]
DR   RefSeq; NP_741404.1; NM_171345.6. [P34707-1]
DR   RefSeq; NP_741405.1; NM_171346.3.
DR   RefSeq; NP_741406.1; NM_171347.7. [P34707-2]
DR   PDB; 1SKN; X-ray; 2.50 A; P=540-623.
DR   PDBsum; 1SKN; -.
DR   AlphaFoldDB; P34707; -.
DR   SMR; P34707; -.
DR   BioGRID; 42465; 25.
DR   FunCoup; P34707; 611.
DR   IntAct; P34707; 5.
DR   STRING; 6239.T19E7.2a.1; -.
DR   BindingDB; P34707; -.
DR   ChEMBL; CHEMBL2146298; -.
DR   iPTMnet; P34707; -.
DR   PaxDb; 6239-T19E7.2a; -.
DR   EnsemblMetazoa; T19E7.2a.1; T19E7.2a.1; WBGene00004804. [P34707-1]
DR   EnsemblMetazoa; T19E7.2b.1; T19E7.2b.1; WBGene00004804. [P34707-2]
DR   EnsemblMetazoa; T19E7.2c.1; T19E7.2c.1; WBGene00004804. [P34707-3]
DR   GeneID; 177343; -.
DR   KEGG; cel:CELE_T19E7.2; -.
DR   UCSC; T19E7.2b; c. elegans. [P34707-1]
DR   AGR; WB:WBGene00004804; -.
DR   CTD; 177343; -.
DR   WormBase; T19E7.2a; CE27591; WBGene00004804; skn-1. [P34707-1]
DR   WormBase; T19E7.2b; CE31238; WBGene00004804; skn-1. [P34707-2]
DR   WormBase; T19E7.2c; CE31239; WBGene00004804; skn-1. [P34707-3]
DR   eggNOG; KOG3863; Eukaryota.
DR   InParanoid; P34707; -.
DR   OMA; TERPRAH; -.
DR   OrthoDB; 7458135at2759; -.
DR   Reactome; R-CEL-8951664; Neddylation.
DR   Reactome; R-CEL-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-CEL-9759194; Nuclear events mediated by NFE2L2.
DR   Reactome; R-CEL-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR   SignaLink; P34707; -.
DR   EvolutionaryTrace; P34707; -.
DR   PRO; PR:P34707; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00004804; Expressed in pharyngeal muscle cell (C elegans) and 5 other cell types or tissues.
DR   ExpressionAtlas; P34707; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:WormBase.
DR   GO; GO:0005739; C:mitochondrion; IDA:WormBase.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; NAS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0030544; F:Hsp70 protein binding; IPI:WormBase.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:WormBase.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:WormBase.
DR   GO; GO:0036500; P:ATF6-mediated unfolded protein response; IDA:WormBase.
DR   GO; GO:0001708; P:cell fate specification; IMP:WormBase.
DR   GO; GO:1990748; P:cellular detoxification; IMP:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB.
DR   GO; GO:0048565; P:digestive tract development; IMP:UniProtKB.
DR   GO; GO:0048566; P:embryonic digestive tract development; IMP:UniProtKB.
DR   GO; GO:0009880; P:embryonic pattern specification; IMP:WormBase.
DR   GO; GO:0001714; P:endodermal cell fate specification; IMP:UniProtKB.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; IEP:WormBase.
DR   GO; GO:0048382; P:mesendoderm development; IMP:WormBase.
DR   GO; GO:1905804; P:positive regulation of cellular response to manganese ion; IMP:UniProtKB.
DR   GO; GO:1900409; P:positive regulation of cellular response to oxidative stress; IMP:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   GO; GO:0009408; P:response to heat; IEP:WormBase.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:WormBase.
DR   GO; GO:1901562; P:response to paraquat; IGI:UniProtKB.
DR   GO; GO:0000303; P:response to superoxide; IMP:WormBase.
DR   Gene3D; 1.10.880.10; Transcription factor, Skn-1-like, DNA-binding domain; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR004826; bZIP_Maf.
DR   InterPro; IPR047167; NFE2-like.
DR   InterPro; IPR008917; TF_DNA-bd_sf.
DR   PANTHER; PTHR24411; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR; 1.
DR   PANTHER; PTHR24411:SF55; SEGMENTATION PROTEIN CAP'N'COLLAR; 1.
DR   Pfam; PF03131; bZIP_Maf; 1.
DR   SUPFAM; SSF47454; A DNA-binding domain in eukaryotic transcription factors; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Cytoplasm;
KW   Developmental protein; DNA-binding; Mitochondrion; Nucleus; Phosphoprotein;
KW   Reference proteome; Stress response; Transcription;
KW   Transcription regulation; Translation regulation.
FT   CHAIN           1..623
FT                   /note="Protein skinhead-1"
FT                   /id="PRO_0000076639"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          158..184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          421..451
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          467..557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          540..623
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        173..184
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..449
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        472..498
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        511..529
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         164
FT                   /note="Phosphoserine; by pmk-1"
FT                   /evidence="ECO:0000269|PubMed:16166371,
FT                   ECO:0000269|PubMed:26920757"
FT   MOD_RES         430
FT                   /note="Phosphoserine; by pmk-1"
FT                   /evidence="ECO:0000269|PubMed:16166371,
FT                   ECO:0000269|PubMed:26920757"
FT   VAR_SEQ         1..313
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_011488"
FT   VAR_SEQ         1..90
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_011487"
FT   VAR_SEQ         314..389
FT                   /note="FDNKQQHPVINNVSLSEGIVYNQANLTEMQEMRDSCNQVSISTIPTTSTAQP
FT                   ETLFNVTDSQTVEQWLPTEVVPND -> MSLPSDFASSLLASSTTTNTTNTAPAAVNSF
FT                   DEQEEESKKILNMYLQMFNQQQVDQHGHHHQHPYAYSGVSSTFDR (in isoform
FT                   b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_011489"
FT   MUTAGEN         164
FT                   /note="S->A: Abolishes phosphorylation by pmk-1. Loss of
FT                   nuclear translocation and increased susceptibility in
FT                   response to arsenite treatment; when associated with A-430.
FT                   Loss of nuclear translocation in a trx-1(ok1449) mutant
FT                   background; when associated with A-430."
FT                   /evidence="ECO:0000269|PubMed:16166371,
FT                   ECO:0000269|PubMed:26920757"
FT   MUTAGEN         237
FT                   /note="E->K: In lax188; small body size, transcriptional
FT                   up-regulation of genes related to metabolism and adaptation
FT                   to starvation, increased length of the reproductive period
FT                   and slower growth recovery following starvation-induced
FT                   arrest at the L1 larval stage."
FT                   /evidence="ECO:0000269|PubMed:23040073"
FT   MUTAGEN         240..623
FT                   /note="Missing: In zu67; abolishes induction of gcs-1,
FT                   gst-4 and gst-7 in combination with RNAi-mediated knockdown
FT                   of hcf-1."
FT                   /evidence="ECO:0000269|PubMed:22568582"
FT   MUTAGEN         245
FT                   /note="S->L: In lax120; small body size, transcriptional
FT                   up-regulation of genes related to metabolism and adaptation
FT                   to starvation, increased length of the reproductive period
FT                   and slower growth recovery following starvation-induced
FT                   arrest at the L1 larval stage."
FT                   /evidence="ECO:0000269|PubMed:23040073"
FT   MUTAGEN         430
FT                   /note="S->A: Abolishes phosphorylation by pmk-1. Loss of
FT                   nuclear translocation and increased susceptibility in
FT                   response to arsenite treatment; when associated with A-164.
FT                   Loss of nuclear translocation in a trx-1(ok1449) mutant
FT                   background; when associated with A-164."
FT                   /evidence="ECO:0000269|PubMed:16166371,
FT                   ECO:0000269|PubMed:26920757"
FT   MUTAGEN         553..623
FT                   /note="Missing: In zu135; susceptibility to P.aeruginosa or
FT                   E.faecalis is characterized by a decrease in survival
FT                   rate."
FT                   /evidence="ECO:0000269|PubMed:34407394"
FT   HELIX           550..557
FT                   /evidence="ECO:0007829|PDB:1SKN"
FT   HELIX           564..569
FT                   /evidence="ECO:0007829|PDB:1SKN"
FT   HELIX           572..581
FT                   /evidence="ECO:0007829|PDB:1SKN"
FT   HELIX           586..615
FT                   /evidence="ECO:0007829|PDB:1SKN"
FT   TURN            616..618
FT                   /evidence="ECO:0007829|PDB:1SKN"
SQ   SEQUENCE   623 AA;  70709 MW;  31A70303AB7CC691 CRC64;
     MGGSSRRQRS TSATRRDDKR RRRQCFSSVA DDEEETTSIY GVSSIFIWIL ATSSLILVIS
     SPSSNTSIQS SSYDRITTKH LLDNISPTFK MYTDSNNRNF DEVNHQHQQE QDFNGQSKYD
     YPQFNRPMGL RWRDDQRMME YFMSNGPVET VPVMPILTEH PPASPFGRGP STERPTTSSR
     YEYSSPSLED IDLIDVLWRS DIAGEKGTRQ VAPADQYECD LQTLTEKSTV APLTAEENAR
     YEDLSKGFYN GFFESFNNNQ YQQKHQQQQR EQIKTPTLEH PTQKAELEDD LFDEDLAQLF
     EDVSREEGQL NQLFDNKQQH PVINNVSLSE GIVYNQANLT EMQEMRDSCN QVSISTIPTT
     STAQPETLFN VTDSQTVEQW LPTEVVPNDV FPTSNYAYIG MQNDSLQAVV SNGQIDYDHS
     YQSTGQTPLS PLIIGSSGRQ QQTQTSPGSV TVTATATQSL FDPYHSQRHS FSDCTTDSSS
     TCSRLSSESP RYTSESSTGT HESRFYGKLA PSSGSRYQRS SSPRSSQSSI KIARVVPLAS
     GQRKRGRQSK DEQLASDNEL PVSAFQISEM SLSELQQVLK NESLSEYQRQ LIRKIRRRGK
     NKVAARTCRQ RRTDRHDKMS HYI
//
